A “new achievement” … a promising drug for the Corona virus… | #coronavirus | #kids. | #children | #schools

The Scottish biotechnology company ILC Therapy has announced that a unique synthetic interferon treatment, called Alphasite, is more effective in preventing the spread of coronaviruses than other commercially available drugs such as Interferon alpha2 and Interferon beta 1A. While Covid-19 disease attempts to slow the body’s innate response to the viral infection, the Alphasite treatment has been designed to help speed up this response and prevent disease progression.

Independent research at the University of St Andrews, led by Dr. Catherine Adamson, of the School of Biology, who specializes in Viral diseasesThe superior effectiveness of Alphasite during laboratory testing against coronaviruses.

Dr. Adamson, who supervised the tests, said: “This is a very exciting development, and it appears that there is a big difference in the vital activity of subtypes of interferons against corona viruses. These differences may have important therapeutic effects for Covid-19.”

The Alphasite Therapy was invented by Professor William Stimson, Founder and Senior Scientific Director, the ILC Therapy Biotechnology Foundation.

Dr. Alan Walker, CEO of the company, welcomed the results as an important development in Combating Covid-19“This is a very positive development, as the world is preparing to face the second wave. Curative interventions are necessary for us to tame the disease,” he said.

He added, “The innate immune system acts as an immune wall against Viral infection. If we can stop the virus at certain limits, and this wall enables the adaptive immune response to be prepared for battle, and Covid-19 will not be able to progress. “

Alpha-interferons are a family of 12 natural proteins. So far, only one therapeutic subtype is used, interferon alpha2.

These were the details of the news A “new achievement” … a promising drug for the Corona virus… for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at eg24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.





Source link